Therapies Archives - Oncology Central Oncology Central

Must read

18 Mar 2020 Clinical trials
HPV vaccine–chemotherapy combination may improve cervical cancer survival

3 Mar 2020 Journal Articles
The role of tumor burden and liver function in therapy selection for HCC patients
19 Feb 2020 Opinion
Capturing Cancer: Oncology Central Photography Competition winners
7 Jan 2020 Lung
KEYNOTE-604 trial demonstrates mixed results for pembrolizumab in small cell lung cancer
7 Jan 2020 Endocrine
Developing therapeutics for endocrine tumors: an interview with Gary Hammer
20 Dec 2019 Opinion
Top 10 oncology news articles of 2019
19 Dec 2019 Opinion
The best of 2019: an A–Z of cancer research and care

Must watch

Stay up to date

Upcoming event

Molecular Analysis for Personalised Therapy Congress 2020

October 8, 2020 – October 10, 2020

Amsterdam, Netherlands

View all

Upcoming event

ESMO World Congress of Gastrointestinal Cancer 2020

July 1, 2020 – July 4, 2020

Barcelona, Spain

View all

Tweets

Oncology Central @OncologyCentral·

Could neoadjuvant #immunotherapy improve survival in #coloncancer? New research from @NKI_nl suggests that this might be the case.

View all

Jobs

Connecting talent with opportunity. View our featured jobs

View all

HPV vaccine–chemotherapy combination may improve cervical cancer survival

The role of tumor burden and liver function in therapy selection for HCC patients

Capturing Cancer: Oncology Central Photography Competition winners

KEYNOTE-604 trial demonstrates mixed results for pembrolizumab in small cell lung cancer

Developing therapeutics for endocrine tumors: an interview with Gary Hammer

Top 10 oncology news articles of 2019

The best of 2019: an A–Z of cancer research and care

ESMO 2019 day 3 highlights: BFAST and ClarIDHy trial findings

CAR-T cell therapy: new hope for mesothelioma patients

Lung Cancer Ambition Alliance with Giorgio Scagliotti

Treatment sequencing in oncology: an interview with Orazio Caffo

Optimizing outcomes and treatment sequences in EGFR mutation-positive NSCLC: recent updates

Fast-acting skin patch shows potential in developing melanoma vaccine

Combination therapy shows promise for drug-resistant acute lymphoblastic leukemia in mice

PARP inhibitors: study uncovers novel mechanism of action

Addressing unmet needs in pancreatic cancer with Pascal Hammel

Treatment options for triple-negative breast cancer with Ahmad Awada

REARRANGE trial shows benefits of flexible dosing pattern to treat refractory metastatic colorectal cancer

Could the common cold virus treat bladder cancer?

E.coli programmed to colonize tumors in mice and deliver immunotherapy

ASCO 2019: what should you look out for?

Novel drug could be world’s first treatment for a pediatric brain cancer

ESMO Breast Cancer 2019: should HER2-positive breast cancer treatment de-escalation be personalized?

Login

Therapies

Must read

HPV vaccine–chemotherapy combination may improve cervical cancer survival

The role of tumor burden and liver function in therapy selection for HCC patients

Capturing Cancer: Oncology Central Photography Competition winners

KEYNOTE-604 trial demonstrates mixed results for pembrolizumab in small cell lung cancer

Developing therapeutics for endocrine tumors: an interview with Gary Hammer

Top 10 oncology news articles of 2019

The best of 2019: an A–Z of cancer research and care

Must watch

ESMO 2019 day 3 highlights: BFAST and ClarIDHy trial findings

CAR-T cell therapy: new hope for mesothelioma patients

Lung Cancer Ambition Alliance with Giorgio Scagliotti

Treatment sequencing in oncology: an interview with Orazio Caffo

Optimizing outcomes and treatment sequences in EGFR mutation-positive NSCLC: recent updates

Fast-acting skin patch shows potential in developing melanoma vaccine

Combination therapy shows promise for drug-resistant acute lymphoblastic leukemia in mice

PARP inhibitors: study uncovers novel mechanism of action

Addressing unmet needs in pancreatic cancer with Pascal Hammel

Treatment options for triple-negative breast cancer with Ahmad Awada

REARRANGE trial shows benefits of flexible dosing pattern to treat refractory metastatic colorectal cancer

Could the common cold virus treat bladder cancer?

E.coli programmed to colonize tumors in mice and deliver immunotherapy

ASCO 2019: what should you look out for?

Novel drug could be world’s first treatment for a pediatric brain cancer

ESMO Breast Cancer 2019: should HER2-positive breast cancer treatment de-escalation be personalized?

Stay up to date

Oncology Central Newsletter